United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. STORY HIGHLIGHTS FDA clears United Therapeutics for human trials of pig-to-human kidney transplants.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

United Therapeutics' clinical trial represents a significant advancement in addressing the organ shortage crisis and improving the survival and quality of life for ESRD patients. With a P/E ratio ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

an experimental but potentially groundbreaking innovation for thousands of Americans on the waiting list for organ transplants. United Therapeutics Corp. said Tuesday that its trial will start ...